Clinical Trials Logo

Granulomatosis, Wegener's clinical trials

View clinical trials related to Granulomatosis, Wegener's.

Filter by:
  • None
  • Page 1

NCT ID: NCT02474888 Terminated - Clinical trials for Microscopic Polyangiitis

Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis

MONITUX
Start date: September 15, 2015
Phase:
Study type: Observational

The aim of the investigators' study is to evaluate whether monitoring serum rituximab levels could be an interesting tool in the follow-up of ANCA-associated vasculitis patients. All consecutive patients, hospitalized for a new diagnosis of ANCA-associated vasculitis or the relapse of a known ANCA-associated vasculitis, in which the decision to start an induction regimen with rituximab has been taken, will be included. Serum rituximab levels (along with serum anti-rituximab antibodies levels) will be determined (at M+1 and M+3) and the correlation with clinical outcome at M+6 will be analyzed.